"We are open and here for you ** UCHealth primary care, urgent care, specialty clinics and hospitals are safe and open. Your safety is our top priority while providing you with the highest level of care."

During the past decade, University of Colorado Leprino Building conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "University of Colorado Leprino Building" are "Respiratory Tract Infection" (2 trials), "Hepatitis C Virus Infection" (1 trials) and "Liver Disease" (1 trials). Many other conditions were trialed in "University of Colorado Leprino Building" in a lesser frequency.

Most popular intervention types in "University of Colorado Leprino Building" are "Biological" (2 trials), "Drug" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "HepQuant-SHUNT (Drug and Device) #65,123 (4D-cholate) and IND #65,121 (13C-cholate)" (1 trials), "Hepatic Venous Pressure Gradient (HVPG)" (1 trials), "RSV vaccine" (1 trials) and "RSVpreF" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Colorado Leprino Building" are 2 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "University of Colorado Leprino Building". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in University of Colorado Leprino Building, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Colorado Leprino Building, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".